RNA Is a Double-Edged Sword in ALS Pathogenesis.

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease impacting motor neurons.
• Familial ALS, linked to mutations in over 10 genes, often involves RNA-binding proteins.
• ALS and frontotemporal dementia (FTD) share genetic links, suggesting common pathogenic mechanisms.

Purpose of the Study:

• To review the roles of altered RNA metabolism and RNA-mediated toxicity in ALS pathogenesis.
• To focus on mutations in TARDBP, FUS, and C9ORF72 genes.
• To explore RNA-based therapeutic strategies for ALS.

Main Methods:

• Literature review of recent studies on ALS and FTD genetics.
• Analysis of research on RNA metabolism defects in neurodegeneration.
• Examination of toxic RNA mechanisms in motor and cortical neuron degeneration.

Main Results:

• Emerging evidence implicates toxic RNA as a potential initiator of neurodegeneration in ALS.
• Specific RNA metabolism pathways are associated with disease progression.
• Mutations in TARDBP, FUS, and C9ORF72 are central to RNA-mediated toxicity in ALS.

Conclusions:

• Altered RNA metabolism and toxic RNA species are critical factors in ALS.
• RNA-based approaches offer promising therapeutic avenues for ALS.
• Further structural studies of RNA-binding proteins are needed for targeted therapies.